Clinical Site 128 — New York, New York

Clinical Site 128 is a clinical research site located in New York, New York, United States 10036.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Clinical Site 128 has participated in 1 clinical trials.

Therapeutic areas: Adjunctive Treatment of Major Depressive Disorder.

Sponsors: Clexio Biosciences Ltd..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Site 128?

Clinical Site 128 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Site 128 conducted?

Clinical Site 128 has 1 clinical trials on record. Their work covers Adjunctive Treatment of Major Depressive Disorder.

Is Clinical Site 128 accredited by Crixeo Health?

Clinical Site 128 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Site 128?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.